Search

everythinglearnresearchcommunity

for

Search:↓

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Some nonsurgical hair loss treatments are effective, especially if started early.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Menopause can cause skin issues, and seeing a dermatologist helps.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The document concludes that understanding hair loss and considering medical treatments like minoxidil and finasteride before surgery is important, especially for young patients with rapid hair loss, and that hairline design varies among different ethnicities.

PCOS may increase the risk of high blood pressure and heart issues.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The document concludes that scalp conditions have various causes and can present in many different ways.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Cosmetic hair treatments can increase hair testosterone levels, while natural hair color does not affect it.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

SHBG may be a useful early indicator and treatment target for PCOS.